Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1991 Aug;103(4):1857–1864. doi: 10.1111/j.1476-5381.1991.tb12342.x

Direct evidence for an important species difference in the mechanism of 8-OH-DPAT-induced hypothermia.

D J Bill 1, M Knight 1, E A Forster 1, A Fletcher 1
PMCID: PMC1908184  PMID: 1833017

Abstract

1. Parallel series of experiments were carried out in the rat and mouse in order to investigate the mechanism(s) underlying the hypothermia induced in rodents by the selective 5-HT1A receptor agonist, 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT). 2. In the mouse, lesioning of central 5-hydroxytryptaminergic neurones (by use of the neurotoxin, 5,7-dihydroxytryptamine; 5,7-DHT) abolished the hypothermic response to 8-OH-DPAT, and depletion of brain 5-hydroxytryptamine (5-HT) levels (with the 5-HT synthesis inhibitor, p-chlorophenylalanine) markedly attenuated the response in this species. These pretreatments did not significantly attenuate 8-OH-DPAT-induced hypothermia in the rat, except for a significant attenuation of the response in 5,7-DHT-lesioned rats at the top dose of 8-OH-DPAT (1.0 mg kg-1, s.c.). 3. Pharmacological pretreatments which facilitate 5-HT release (selective 5-HT uptake inhibitors, precursor (5-hydroxytryptophan) loading, or fenfluramine), markedly attenuated or abolished 8-OH-DPAT-induced hypothermia in the mouse. These pretreatments generally had no significant effect on 8-OH-DPAT-induced hypothermia in the rat. 4. The selective noradrenaline uptake inhibitor, desipramine, had no effect on the hypothermic response to 8-OH-DPAT in either species. The selective dopamine uptake inhibitor, nomifensin, significantly increased the hypothermic response to 8-OH-DPAT in the mouse, but did not affect the response in the rat except at high, motor stimulant doses, when the response was attenuated. 5. These data are consistent with the hypothesis that 8-OH-DPAT-induced hypothermia is mediated by presynaptic autoreceptors in the mouse and by postsynaptic 5-HT1A receptors in the rat.(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
1857

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Billingsley A. J., Brammer N. T., Wood M. D., Minchin M. C. A comparison of the effects of the selective 5-HT uptake inhibitor WY 27587 on 5-HT uptake into platelets and synaptosomes in the rat. Neuropharmacology. 1989 Jan;28(1):33–36. doi: 10.1016/0028-3908(89)90064-6. [DOI] [PubMed] [Google Scholar]
  2. Blackburn T. P., Cox B., Thornber C. W., Pearce R. J. Pharmacological studies in vivo with ICI 169,369, a chemically novel 5-HT2/5-HT1C receptor antagonist. Eur J Pharmacol. 1990 May 16;180(2-3):229–237. doi: 10.1016/0014-2999(90)90306-q. [DOI] [PubMed] [Google Scholar]
  3. Blurton P. A., Broadhurst A. M., Cross J. A., Ennis C., Wood M. D., Wyllie M. G. Panuramine, a selective inhibitor of uptake of 5-hydroxytryptamine in the brain of the rat. Neuropharmacology. 1984 Sep;23(9):1049–1052. doi: 10.1016/0028-3908(84)90127-8. [DOI] [PubMed] [Google Scholar]
  4. Brittain R. T. The intracerebral effects of noradrenaline and its modification by drugs in the mouse. J Pharm Pharmacol. 1966 Sep;18(9):621–623. doi: 10.1111/j.2042-7158.1966.tb07944.x. [DOI] [PubMed] [Google Scholar]
  5. Dourish C. T., Hutson P. H., Curzon G. Para-chlorophenylalanine prevents feeding induced by the serotonin agonist 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT). Psychopharmacology (Berl) 1986;89(4):467–471. doi: 10.1007/BF02412123. [DOI] [PubMed] [Google Scholar]
  6. Engel G., Göthert M., Hoyer D., Schlicker E., Hillenbrand K. Identity of inhibitory presynaptic 5-hydroxytryptamine (5-HT) autoreceptors in the rat brain cortex with 5-HT1B binding sites. Naunyn Schmiedebergs Arch Pharmacol. 1986 Jan;332(1):1–7. doi: 10.1007/BF00633189. [DOI] [PubMed] [Google Scholar]
  7. Goodwin G. M., De Souza R. J., Green A. R., Heal D. J. The pharmacology of the behavioural and hypothermic responses of rats to 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT). Psychopharmacology (Berl) 1987;91(4):506–511. doi: 10.1007/BF00216019. [DOI] [PubMed] [Google Scholar]
  8. Goodwin G. M., De Souza R. J., Green A. R. The pharmacology of the hypothermic response in mice to 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT). A model of presynaptic 5-HT1 function. Neuropharmacology. 1985 Dec;24(12):1187–1194. doi: 10.1016/0028-3908(85)90153-4. [DOI] [PubMed] [Google Scholar]
  9. Gudelsky G. A., Koenig J. I., Meltzer H. Y. Thermoregulatory responses to serotonin (5-HT) receptor stimulation in the rat. Evidence for opposing roles of 5-HT2 and 5-HT1A receptors. Neuropharmacology. 1986 Dec;25(12):1307–1313. doi: 10.1016/0028-3908(86)90101-2. [DOI] [PubMed] [Google Scholar]
  10. Hjorth S. Hypothermia in the rat induced by the potent serotoninergic agent 8-OH-DPAT. J Neural Transm. 1985;61(1-2):131–135. doi: 10.1007/BF01253058. [DOI] [PubMed] [Google Scholar]
  11. Hutson P. H., Donohoe T. P., Curzon G. Hypothermia induced by the putative 5-HT1A agonists LY165163 and 8-OH-DPAT is not prevented by 5-HT depletion. Eur J Pharmacol. 1987 Nov 10;143(2):221–228. doi: 10.1016/0014-2999(87)90536-x. [DOI] [PubMed] [Google Scholar]
  12. Middlemiss D. N., Fozard J. R. 8-Hydroxy-2-(di-n-propylamino)-tetralin discriminates between subtypes of the 5-HT1 recognition site. Eur J Pharmacol. 1983 May 20;90(1):151–153. doi: 10.1016/0014-2999(83)90230-3. [DOI] [PubMed] [Google Scholar]
  13. Preston E., Ma S., Haas N. Ambient temperature modulation of fenfluramine-induced thermogenesis in the rat. Neuropharmacology. 1990 Mar;29(3):277–283. doi: 10.1016/0028-3908(90)90013-h. [DOI] [PubMed] [Google Scholar]
  14. Schlicker E., Fink K., Göthert M., Hoyer D., Molderings G., Roschke I., Schoeffter P. The pharmacological properties of the presynaptic serotonin autoreceptor in the pig brain cortex conform to the 5-HT1D receptor subtype. Naunyn Schmiedebergs Arch Pharmacol. 1989 Jul;340(1):45–51. doi: 10.1007/BF00169206. [DOI] [PubMed] [Google Scholar]
  15. Sulpizio A., Fowler P. J., Macko E. Antagonism of fenfluramine-induced hyperthermia: a measure of central serotonin inhibition. Life Sci. 1978 Apr 24;22(16):1439–1446. doi: 10.1016/0024-3205(78)90638-0. [DOI] [PubMed] [Google Scholar]
  16. Tricklebank M. D., Forler C., Fozard J. R. The involvement of subtypes of the 5-HT1 receptor and of catecholaminergic systems in the behavioural response to 8-hydroxy-2-(di-n-propylamino)tetralin in the rat. Eur J Pharmacol. 1984 Nov 13;106(2):271–282. doi: 10.1016/0014-2999(84)90714-3. [DOI] [PubMed] [Google Scholar]
  17. Wagner J., Vitali P., Palfreyman M. G., Zraika M., Huot S. Simultaneous determination of 3,4-dihydroxyphenylalanine, 5-hydroxytryptophan, dopamine, 4-hydroxy-3-methoxyphenylalanine, norepinephrine, 3,4-dihydroxyphenylacetic acid, homovanillic acid, serotonin, and 5-hydroxyindoleacetic acid in rat cerebrospinal fluid and brain by high-performance liquid chromatography with electrochemical detection. J Neurochem. 1982 May;38(5):1241–1254. doi: 10.1111/j.1471-4159.1982.tb07897.x. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES